Tianjin Lisheng Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Lisheng Pharmaceutical Company Limited with three other
companies in this sector in China:
Zhejiang Jolly Pharmaceutical Co Ltd
sales of 840.04 million Chinese Renmimbi [US$131.17 million]
of which 80%
Anhui Anke Biotechnology (Group) Company., Limited
(849.19 million Chinese Renmimbi [US$132.60 million]
of which 57%
was Biological Products), and
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
(849.33 million Chinese Renmimbi [US$132.62 million]
of which 100%
was Medicine Product).
During the year ended December of 2016, sales at
Tianjin Lisheng Pharmaceutical Company Limited were 846.83 million Chinese Renmimbi (US$132.23 million).
increase of 9.3%
versus 2015, when the company's sales were 774.67 million Chinese Renmimbi.